Revonto - 27505-003-67 - (dantrolene sodium)

Alphabetical Index


Drug Information of Revonto

Product NDC: 27505-003
Proprietary Name: Revonto
Non Proprietary Name: dantrolene sodium
Active Ingredient(s): 20    mg/60mL & nbsp;   dantrolene sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Revonto

Product NDC: 27505-003
Labeler Name: US WorldMeds, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078378
Marketing Category: ANDA
Start Marketing Date: 20120604

Package Information of Revonto

Package NDC: 27505-003-67
Package Description: 6 VIAL, GLASS in 1 CARTON (27505-003-67) > 60 mL in 1 VIAL, GLASS

NDC Information of Revonto

NDC Code 27505-003-67
Proprietary Name Revonto
Package Description 6 VIAL, GLASS in 1 CARTON (27505-003-67) > 60 mL in 1 VIAL, GLASS
Product NDC 27505-003
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name dantrolene sodium
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120604
Marketing Category Name ANDA
Labeler Name US WorldMeds, LLC
Substance Name DANTROLENE SODIUM
Strength Number 20
Strength Unit mg/60mL
Pharmaceutical Classes Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC]

Complete Information of Revonto


General Information